Deleobuvir ylamino-Val-Cit-OH 3-thiazol-2-yl)amino]pyridin-2-yl}methyl)cyclohexane-1-carboxylic acid

3-thiazol-2-yl)amino]pyridin-2-yl}methyl)cyclohexane-1-carboxylic acid

is a competitive inhibitor that quantitatively blocks the effect of androgens on LNCaP cell growth

twice-daily

Specificity of polyclonal antibodies raised against a novel 24

CAS Number: 2055013-49-3

Deleobuvir ylamino-Val-Cit-OH 3-thiazol-2-yl)amino]pyridin-2-yl}methyl)cyclohexane-1-carboxylic acidDeleobuvir, also known as BI207127, a non nucleoside hepatitis C virus NS5B polymerase inhibitor for the treatment of hepatitis C. Deleobuvir was tested in combination regimens with pegylated interferon and ribavirin, and in interferon free regimens with other direct acting antiviral agents including faldaprevir. Deleobuvir showed that a triple combination of deleobuvir, faldaprevir, and ribavirin performed well in HCV genotype 1b patients. Efficacy